Expression of multidrug resistance-associated protein (MRP) in anaplastic carcinoma of the thyroid.
Although the incidence is very low, the prognosis of anaplastic carcinoma of the thyroid is very poor regardless of the results of various therapeutic trials. We found that the mechanism of anti-cancer drug resistance in anaplastic carcinoma of the thyroid was not explicable only in terms of expression of the mdr1 and its gene product, P-glycoprotein. Therefore, expression of multidrug resistance-associated protein (MRP) mRNA was examined in 11 anaplastic thyroid carcinomas and eight anaplastic thyroid carcinoma cell lines. High MRP mRNA expression was recognized in 7/11 and 8/8, respectively. Our results may contribute to elucidation of the mechanism of anti-cancer drug resistance in this neoplasm.
Sugawara
I
I
Department of Pathology, Saitama Medical School, Japan.
Arai
T
T
Yamashita
T
T
Yoshida
A
A
Masunaga
A
A
Itoyama
S
S
D001483:Base Sequence; D002277:Carcinoma / Q000737:chemistry*; D004351:Drug Resistance; D006801:Humans; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000032:analysis*; D012333:RNA, Messenger / Q000032:analysis; D012334:RNA, Neoplasm / Q000032:analysis; D013964:Thyroid Neoplasms / Q000737:chemistry*; D014407:Tumor Cells, Cultured
D009363:Neoplasm Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm